Compare WST & DECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | DECK |
|---|---|---|
| Founded | 1923 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 15.0B |
| IPO Year | N/A | 1993 |
| Metric | WST | DECK |
|---|---|---|
| Price | $275.53 | $104.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 22 |
| Target Price | ★ $345.75 | $121.63 |
| AVG Volume (30 Days) | 682.9K | ★ 3.0M |
| Earning Date | 02-12-2026 | 01-29-2026 |
| Dividend Yield | ★ 0.32% | N/A |
| EPS Growth | 0.17 | ★ 18.83 |
| EPS | ★ 6.75 | 6.75 |
| Revenue | $3,017,900,000.00 | ★ $5,244,323,000.00 |
| Revenue This Year | $7.01 | $9.86 |
| Revenue Next Year | $6.20 | $7.38 |
| P/E Ratio | $41.01 | ★ $15.56 |
| Revenue Growth | 4.92 | ★ 12.62 |
| 52 Week Low | $187.43 | $78.91 |
| 52 Week High | $348.90 | $223.98 |
| Indicator | WST | DECK |
|---|---|---|
| Relative Strength Index (RSI) | 52.34 | 63.12 |
| Support Level | $272.53 | $99.50 |
| Resistance Level | $277.75 | $105.81 |
| Average True Range (ATR) | 5.66 | 2.50 |
| MACD | 0.56 | 0.00 |
| Stochastic Oscillator | 72.82 | 75.75 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2025, Ugg and Hoka accounted for 51% and 45% of total sales, respectively. The firm also markets niche brands Teva and Ahnu. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has nearly 200 company-operated stores. It generated 64% of its fiscal 2025 sales in the United States.